Identification and characterization of predictive and prognostic markers in neuroendocrine neoplasms

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038744

Enrollment

1000

Registered

2025-12-18

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C75

Interventions

Group 1: Retrospective analysis of tissue and section preparations of neuroendocrine neoplasms routinely archived in pathology after completion of diagnostics, correlated with clinical follow-up data.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Histologically confirmed neuroendocrine neoplasm

Exclusion criteria

Exclusion criteria: Histologically excluded neuroendocrine neoplasm

Design outcomes

Primary

Measure	Time frame
Immunohistochemical expression after staining (present vs. loss of expression). Correlation with clinical follow-up data already collected. Disease-free survival, overall survival time.	—

Countries

Germany

Contacts

Public ContactSebastian Graf

Universitätsklinikum Heidelberg, pathologisches Institut

sebastian.graf@med.uni-heidelberg.de+49 6221 56 - 310150

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026